Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 August, 2018 16:16 IST
Suven Life Sciences secures 2 overseas product patents
Source: IRIS | 06 Dec, 2017, 10.35AM
Comments  |  Post Comment

Suven Life Sciences announces today that the grant of one product patent from Eurasia and one product patent from Norway corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034 and 2026 respectively.

The granted claims of the patents include the class of selective 5-HT6 compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia.

''We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,'' said Venkat Jasti, CEO of Suven. 

Shares of the company gained Rs 8, or 4.2%, to trade at Rs 198.55. The total volume of shares traded was 15,809 at the BSE (10.24 a.m., Wednesday).



Suven Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
MCX inks MoU with Indian Bullion and Jewellers Association - 16-Aug-2018 15:31
Alfa Transformers bags order worth Rs 171.1 mn from Uttar Gujarat Vij Co - 16-Aug-2018 12:25
TVS Motor Co bets big on Philippines with new product launches - 16-Aug-2018 09:54
Sun Pharma gets USFDA approval for Cequa ophthalmic solution - 16-Aug-2018 09:33
TCS named leader in KYC-AML BPO services by Everest Group - 14-Aug-2018 12:04
MCX to commence trading in rubber futures on August 16 - 14-Aug-2018 11:53
Cadila Healthcare acquires 51% stake in Windlas Healthcare - 13-Aug-2018 15:52
RCom re-instates bank guarantees of Rs 7.74 bn with DOT - 13-Aug-2018 12:08
Larsen & Tubro wins construction order worth Rs 30.28 bn - 13-Aug-2018 11:51
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer